Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors
Open Access
- 1 March 2013
- journal article
- Published by Bioscientifica in Endocrine Connections
- Vol. 2 (1), 50-54
- https://doi.org/10.1530/ec-12-0077
Abstract
Neuroendocrine tumors (NETs) arising in the small intestine are known to produce vasoactive substances, including serotonin, that may result in the carcinoid syndrome (flushing, diarrhea, bronchoconstriction, and carcinoid heart disease). Measurement of the serotonin breakdown product 5-hydroxyindoleacetic acid (5-HIAA) in urine is important in diagnosing and monitoring of patients with intestinal NETs. Our aim was to compare 5-HIAA measurement in 24-h urine sampling with overnight (∼8-h) sampling in patients with known NETs, or at follow-up of patients potentially cured for their NETs. Twenty-four-hour and overnight urine samples were collected from 34 patients and analyzed for urinary 5-HIAA (U5-HIAA) using HPLC. Comparison of the overnight sampling values with the 24-h values showed no difference, P=0.45, and there was a significant direct correlation between the two samples using linear regression (R=0.97, P<0.001). U5-HIAA sample collection during a nightly interval of ∼8 h appears to have the same accuracy as the 24-h collection in this group of patients.Keywords
This publication has 21 references indexed in Scilit:
- ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell CarcinomasNeuroendocrinology, 2012
- Activin A in Carcinoid Heart Disease: A Possible Role in Diagnosis and PathogenesisNeuroendocrinology, 2010
- NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine TumorPancreas, 2010
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical MarkersNeuroendocrinology, 2009
- Neuroendocrine tumors of the gastro-entero-pancreatic systemWorld Journal of Gastroenterology, 2008
- Carcinoid Heart DiseaseCirculation, 2007
- Long‐Acting Octreotide and Prolonged‐Release Lanreotide Formulations Have Different Pharmacokinetic ProfilesThe Journal of Clinical Pharmacology, 2005
- Diagnostic, surgical and medical aspect of the midgut carcinoidsCancer Treatment Reviews, 2002
- High performance liquid chromatographic profiling of tryptophan and related indoles in body fluids and tissues of carcinoid patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- Urinary serotonin in the diagnosis of carcinoid tumors.Clinical Chemistry, 1986